Use of measurements of myoglobin and cardiac troponins in the diagnosis of acute myocardial infarction.

M. J. Murphy, C. B. Berding

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

Research indicates that no tests of a single cardiac marker are 100% specific and sensitive for diagnosis of AMI in all patients. Each biomarker has advantages and disadvantages (see Table). Over-reliance on a single diagnostic test is risky. Specific tests should be ordered on the basis of the individual patient's assessment and medical history. Nurses are an important link in the collection of patients' medical history and in assessment as well as in the interpretation of patients' laboratory results. A knowledge of diagnostic tests commonly used in the care of patients with ischemic heart disease is imperative if patients are to receive appropriate, timely, cost-effective care.

Original languageEnglish (US)
Pages (from-to)58-66
Number of pages9
JournalCritical care nurse
Volume19
Issue number1
StatePublished - Feb 1 1999

ASJC Scopus subject areas

  • Critical Care

Fingerprint Dive into the research topics of 'Use of measurements of myoglobin and cardiac troponins in the diagnosis of acute myocardial infarction.'. Together they form a unique fingerprint.

  • Cite this